Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 767

Similar articles for PubMed (Select 15076823)

1.

Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.

Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, Fahey A.

Med Care. 2004 Mar;42(3):239-50.

PMID:
15076823
2.

Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.

Shavers VL, Brown ML, Potosky AL, Klabunde CN, Davis WW, Moul JW, Fahey A.

J Gen Intern Med. 2004 Feb;19(2):146-55.

3.

Race/ethnicity, risk perception, and receipt of prostate-specific antigen testing.

Shavers VL, Underwood W 3rd, Moser RP.

J Natl Med Assoc. 2009 Jul;101(7):698-704.

PMID:
19634591
4.

Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.

Underwood W 3rd, Jackson J, Wei JT, Dunn R, Baker E, Demonner S, Wood DP.

Cancer. 2005 Feb 1;103(3):538-45.

5.

Race and sex differences in the receipt of timely and appropriate lung cancer treatment.

Shugarman LR, Mack K, Sorbero ME, Tian H, Jain AK, Ashwood JS, Asch SM.

Med Care. 2009 Jul;47(7):774-81. doi: 10.1097/MLR.0b013e3181a393fe.

PMID:
19536007
6.

Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.

Hoffman RM, Gilliland FD, Eley JW, Harlan LC, Stephenson RA, Stanford JL, Albertson PC, Hamilton AS, Hunt WC, Potosky AL.

J Natl Cancer Inst. 2001 Mar 7;93(5):388-95.

7.

Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States).

Cohen JH, Schoenbach VJ, Kaufman JS, Talcott JA, Schenck AP, Peacock S, Symons M, Amamoo MA, Carpenter WR, Godley PA.

Cancer Causes Control. 2006 Aug;17(6):803-11.

PMID:
16783608
8.
9.

Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?

Keating NL, Kouri E, He Y, Weeks JC, Winer EP.

Med Care. 2009 Jul;47(7):765-73. doi: 10.1097/MLR.0b013e31819e1fe7.

PMID:
19536008
10.

Trends and black/white differences in treatment for nonmetastatic prostate cancer.

Klabunde CN, Potosky AL, Harlan LC, Kramer BS.

Med Care. 1998 Sep;36(9):1337-48.

PMID:
9749657
11.

Association of African-American ethnic background with survival in men with metastatic prostate cancer.

Thompson I, Tangen C, Tolcher A, Crawford E, Eisenberger M, Moinpour C.

J Natl Cancer Inst. 2001 Feb 7;93(3):219-25.

12.

Decrease in racial disparities in the staging evaluation for prostate cancer after publication of staging guidelines.

Abraham N, Wan F, Montagnet C, Wong YN, Armstrong K.

J Urol. 2007 Jul;178(1):82-7; discussion 87. Epub 2007 May 11.

PMID:
17499294
13.

Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.

Harlan SR, Cooperberg MR, Elkin E, Lubeck DP, Meng M, Mehta SS, Carroll PR.

J Urol. 2003 Nov;170(5):1804-7.

PMID:
14532780
14.

Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor.

Koppie TM, Grossfeld GD, Miller D, Yu J, Stier D, Broering JM, Lubeck D, Henning JM, Flanders SC, Carroll PR.

J Urol. 2000 Jul;164(1):81-8.

PMID:
10840429
15.

The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliates.

Pan CC, Lee JS, Chan JL, Sandler HM, Underwood W, McLaughlin PW.

Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1292-6.

PMID:
14630264
16.

Racial differences in screening for prostate cancer in the elderly.

Gilligan T, Wang PS, Levin R, Kantoff PW, Avorn J.

Arch Intern Med. 2004 Sep 27;164(17):1858-64.

PMID:
15451760
17.
18.

Age-, race-, and ethnicity-related differences in the treatment of nonmetastatic rectal cancer: a patterns of care study from the national cancer data base.

Esnaola NF, Stewart AK, Feig BW, Skibber JM, Rodriguez-Bigas MA.

Ann Surg Oncol. 2008 Nov;15(11):3036-47. doi: 10.1245/s10434-008-0106-9. Epub 2008 Aug 19.

PMID:
18712449
19.
20.

Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999.

Zeliadt SB, Potosky AL, Etzioni R, Ramsey SD, Penson DF.

Urology. 2004 Dec;64(6):1171-6.

PMID:
15596192
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk